Mercury Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-24.
Mercury Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 24, 2025. The filing reports $2.38M sold. Its industry group is Biotechnology. It names Paul Laur (Executive Officer, Director), Steve Kiziuk (Director), Alex Koglin (Director) (SEC Form D, October 24, 2025).
Is this your company?
Sell to companies like Mercury Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Mercury Bio, Inc.
Free to see. No signup.
More on the people and the money behind Mercury Bio, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Mercury Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Mercury Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Mercury Bio, Inc. →Get the full cited report on Mercury Bio, Inc.
What the filing shows about Mercury Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Mercury Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Mercury Bio, Inc.'s address as 3900 Paseo Del Sol, Santa Fe, NM 87507.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Mercury Bio, Inc. is a registered filer with the SEC (CIK 1952927) and has filed since 2022-11-14. 5 filings are on record, the latest on 2025-10-24.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Mercury Bio, Inc.'s Form D of 2025-10-24 names Paul Laur, Steve Kiziuk, Alex Koglin and 5 more as its officers, directors or promoters.
Its new offerings report $3.88M sold across 5 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
With a focus on advanced bio-molecular drug delivery systems, Mercury Bio is developing the therapeutic technologies to help more people heal more effectively.
The title and description the site itself served, answering 200, after redirecting from https://mercurybio.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Paul Laur is named as Executive Officer and Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
Steve Kiziuk is named as Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
Alex Koglin is named as Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
Dana Barnard is named as Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
Bruce McCormick is named as Executive Officer and Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
Kevin McDonald is named as Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
Mike Rice is named as Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
John Tomes is named as Director on the Form D that Mercury Bio, Inc. filed with the SEC on 24 October 2025, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2025-10-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Mercury Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Mercury Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Mercury Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Mercury Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Mercury Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (mercurybio.com).
Each opens in a new tab, filled in for Mercury Bio, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/mercury-bio-inc-form-d-25000001